About Sakae Asanuma
Sakae Asanuma is a director at Crossbow Therapeutics.
Sakae Asanuma reports to the SEC as a director or major shareholder of 1 public company: Werewolf Therapeutics (HOWL).
Sakae Asanuma first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Sakae Asanuma in the role, so the role may have started earlier or lasted longer.
WI
Werewolf Therapeutics, Inc.
Director and 10% owner
2021 · Public company (HOWL)
Key Colleagues at Startups
The people Sakae Asanuma works with at each company, as listed on that company's latest Form D.
Crossbow Therapeutics, Inc. · Form D, Sep 30, 2025
AN
Alexander Nolte
Executive officer
Alexandra Cantley
Director
DW
Dmitri Wiederschain
Executive officer
CB
Charles Baum
Director
Briggs Morrison
Chief Executive Officer and director
IM
Irena Melnikova
Director
AL
Alon Lazarus
Director
TF
Todd Foley
Director